- Home
- RADX vs GROW Comparison
RADX vs GROW Comparison
Compare RADX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- GROW
- Stock Information
- Founded
- RADX 2021
- GROW 1968
- Country
- RADX Australia
- GROW United States
- Employees
- RADX N/A
- GROW N/A
- Industry
- RADX
- GROW Investment Managers
- Sector
- RADX
- GROW Finance
- Exchange
- RADX NYSE
- GROW Nasdaq
- Market Cap
- RADX 32.5M
- GROW 31.8M
- IPO Year
- RADX N/A
- GROW N/A
- Fundamental
- Price
- RADX $4.25
- GROW $2.47
- Analyst Decision
- RADX Strong Buy
- GROW
- Analyst Count
- RADX 2
- GROW 0
- Target Price
- RADX $13.50
- GROW N/A
- AVG Volume (30 Days)
- RADX 19.3K
- GROW 43.8K
- Earning Date
- RADX 02-26-2025
- GROW 09-09-2025
- Dividend Yield
- RADX N/A
- GROW 3.61%
- EPS Growth
- RADX N/A
- GROW N/A
- EPS
- RADX N/A
- GROW 0.01
- Revenue
- RADX $204,609.00
- GROW $8,932,000.00
- Revenue This Year
- RADX N/A
- GROW N/A
- Revenue Next Year
- RADX N/A
- GROW N/A
- P/E Ratio
- RADX N/A
- GROW $230.51
- Revenue Growth
- RADX N/A
- GROW N/A
- 52 Week Low
- RADX $3.50
- GROW $2.02
- 52 Week High
- RADX $50.82
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- GROW 56.26
- Support Level
- RADX N/A
- GROW $2.35
- Resistance Level
- RADX N/A
- GROW $2.49
- Average True Range (ATR)
- RADX 0.00
- GROW 0.10
- MACD
- RADX 0.00
- GROW -0.01
- Stochastic Oscillator
- RADX 0.00
- GROW 36.36
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.